AUPH - Aurinia Pharma GAAP EPS of -$0.09 beats by $0.08 revenue of $54.52M beats by $16.02M
2023-11-02 06:02:25 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals: Reassessing As It Gains Traction
- Aurinia Rides High On Lupkynis, But Not Without Cost (Rating Upgrade)
- Aurinia Pharma Q3 2023 Earnings Preview
- Aurinia reaches truce with major shareholder in new board appointment
- Seeking Alpha’s Quant Rating on Aurinia Pharma
For further details see:
Aurinia Pharma GAAP EPS of -$0.09 beats by $0.08, revenue of $54.52M beats by $16.02M